MASSIRONI, SARA
 Distribuzione geografica
Continente #
AS - Asia 3.288
NA - Nord America 3.172
EU - Europa 1.775
SA - Sud America 421
AF - Africa 81
OC - Oceania 5
Totale 8.742
Nazione #
US - Stati Uniti d'America 3.087
SG - Singapore 1.028
VN - Vietnam 814
CN - Cina 536
HK - Hong Kong 456
IT - Italia 447
RU - Federazione Russa 360
BR - Brasile 313
DE - Germania 240
IE - Irlanda 182
SE - Svezia 170
FR - Francia 84
IN - India 75
GB - Regno Unito 70
KR - Corea 59
BD - Bangladesh 49
ID - Indonesia 48
AR - Argentina 40
CA - Canada 38
FI - Finlandia 37
MX - Messico 34
NL - Olanda 29
SA - Arabia Saudita 29
UA - Ucraina 28
PL - Polonia 27
ZA - Sudafrica 27
ES - Italia 25
IQ - Iraq 25
JP - Giappone 25
PH - Filippine 23
AT - Austria 22
TR - Turchia 22
CH - Svizzera 21
PK - Pakistan 20
PE - Perù 14
VE - Venezuela 14
EC - Ecuador 13
KE - Kenya 13
CO - Colombia 11
MY - Malesia 11
MA - Marocco 10
UZ - Uzbekistan 10
EG - Egitto 9
BE - Belgio 8
JO - Giordania 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 6
TW - Taiwan 6
JM - Giamaica 5
MM - Myanmar 5
TH - Thailandia 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
LT - Lituania 4
SN - Senegal 4
LB - Libano 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
BG - Bulgaria 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
SR - Suriname 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MQ - Martinica 1
NC - Nuova Caledonia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.742
Città #
Singapore 714
Ann Arbor 510
Hong Kong 446
Ashburn 338
San Jose 322
Ho Chi Minh City 256
Hanoi 185
Dublin 177
Frankfurt am Main 155
Los Angeles 122
Chandler 118
Hefei 117
Milan 115
Chicago 93
New York 92
Dallas 80
Beijing 77
Santa Clara 75
Fairfield 67
Wilmington 65
The Dalles 60
Shanghai 55
Council Bluffs 53
Seoul 50
Buffalo 47
Houston 43
Moscow 42
Princeton 41
Lauterbourg 38
Haiphong 36
Jakarta 34
Da Nang 32
São Paulo 32
Woodbridge 32
London 28
Seattle 26
Helsinki 25
Munich 23
Rome 23
Cambridge 22
Orem 21
Florence 20
Lawrence 20
Warsaw 20
Ha Long 19
Tokyo 19
Altamura 17
Guangzhou 17
Nuremberg 17
Rio de Janeiro 17
San Diego 17
Zurich 17
Biên Hòa 16
Denver 16
Hải Dương 16
Ninh Bình 16
Chennai 15
Bắc Ninh 14
Dhaka 14
Hangzhou 14
Montreal 14
Phoenix 14
Thái Nguyên 13
Stockholm 12
Bari 11
Lima 11
Mexico City 11
Salt Lake City 11
Atlanta 10
Johannesburg 10
Tashkent 10
Vũng Tàu 10
Bình Dương 9
Bắc Giang 9
Davao City 9
Guayaquil 9
Mumbai 9
Nairobi 9
Bologna 8
Brasília 8
Brooklyn 8
Can Tho 8
Jeddah 8
Naples 8
Phủ Lý 8
Quận Một 8
Roccalumera 8
Toronto 8
Vienna 8
Amman 7
Belo Horizonte 7
Boardman 7
Boston 7
Cairo 7
Desio 7
Garbagnate Milanese 7
Kuala Lumpur 7
Lang Son 7
Miami 7
Quận Bình Thạnh 7
Totale 5.564
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 726
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 329
Understanding short bowel syndrome: Current status and future perspectives 314
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 307
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 305
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 292
High rates of 30-day mortality in patients with cirrhosis and COVID-19 287
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 273
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 273
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 271
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 268
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 266
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 225
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 225
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 224
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 216
Eosinophilic esophagitis: does age matter? 214
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 214
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 210
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 206
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 204
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 191
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 183
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 177
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 172
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 169
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 166
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 165
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 157
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 155
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 154
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 137
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 133
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 132
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 131
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 129
Systematic review-Pancreatic involvement in inflammatory bowel disease 128
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 123
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 118
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 111
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 111
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 106
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 26
Totale 8.923
Categoria #
all - tutte 29.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 44 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.891 90 164 157 77 148 99 137 57 152 334 207 269
2025/20264.651 979 397 318 556 549 246 684 187 333 333 69 0
Totale 8.923